Avondale Partners Downgrades Allscripts (MDRX) Two Notches to 'Underperform'
Tweet
Share
E-mailGet Alerts MDRX Hot Sheet
Price: $4.90 +2.08%
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Rating Summary:
8 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Join SI Premium – FREE
Avondale Partners downgraded Allscripts (NASDAQ: MDRX) from Market Outperform to Underperform with a price target of $7.00.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $16.02 yesterday.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $16.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Downgrades Legal & General Group PLC (LGEN:LN) (LGGNF) to Sell
- Cannonball Research Downgrades The Trade Desk (TTD) to Neutral
- ICICI Securities Downgrades Biocon Ltd (BIOS:IN) to Sell (5)
Create E-mail Alert Related Categories
DowngradesRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
